Doca-Pharma SRL
0.6 FTEThe score of Doca-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Doca-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
Doca-Pharma's financial analysis
- Solvency-110.2%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Doca-Pharma
Doca-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.386.219
- VAT number
- BE1013386219
- Peppol
- Registered · 0208:1013386219 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Sep 2024
- Registered office
- 9112 Sint-Niklaas
- Size
- Micro · 0.6 FTE
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Doca-Pharma (SRL) has been based in Sint-Niklaas since 2024, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 64,546 € and equity of −79,753 €; its revenue is not published. With 0.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -110.2%, below the median of its sector (46.0%).
Companies similar to Doca-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Hipra Benelux Manufacture of other chemical products n.e.c. Ghent · balance sheet €4.96m
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- World OF Medical Technology Wholesale of pharmaceutical and medical goods Saint-Gilles · balance sheet 41,190 €
- Ulmedt Wholesale of pharmaceutical and medical goods Diepenbeek · balance sheet 87,797 €
- QS Supplements Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Edegem · balance sheet 91,588 €
- Vitaal Wholesale of pharmaceutical and medical goods Schoten · balance sheet 45,344 €
- Futtitinni Wholesale of pharmaceutical and medical goods Uccle · balance sheet 129,363 €
- Orbi-Pharma International Wholesale of pharmaceutical and medical goods Bierbeek · balance sheet 161,674 €
Frequently asked questions about Doca-Pharma
What is the revenue of Doca-Pharma?
Doca-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Doca-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1013386219 for Doca-Pharma, if the company is VAT-registered. Its company number (CBE) is 1013.386.219.
Where is the registered office of Doca-Pharma?
According to the CBE register, the registered office of Doca-Pharma is in 9112 Sint-Niklaas.
What is the equity of Doca-Pharma?
At the close of the 2025 financial year, the equity of Doca-Pharma amounts to -79,753 €, a solvency of -110.2% of total assets.
How many people work at Doca-Pharma?
0.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Doca-Pharma?
The register lists 2 active mandates at Doca-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Doca-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →